Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s share price rose 1.8% during mid-day trading on Wednesday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The firm has a market cap of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The company’s fifty day moving average is C$0.58 and its 200 day moving average is C$0.58. The company has a quick ratio of 9.41, a current ratio of 9.74 and a debt-to-equity ratio of 0.52.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- Bank Stocks – Best Bank Stocks to Invest In
- Should You Invest in Treasury Bills?
- Top Stocks Investing in 5G Technology
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
